Code Ocean collaborates with Lantern Pharma

Code Ocean, the leading computational research environment for sharing scientific discoveries, today announced a collaboration that will power AI-driven computational research for oncology-focused drug discovery with Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development. By leveraging Code Ocean's Compute Capsule technology, the move will further power Lantern Pharma's RADR platform for faster, more collaborative discoveries from billions of RADR data points as well as from experimental results and insights from their network of collaborators. Computational researchers today are challenged with analysing big data with too many tools, lack of specialized coding experience, and challenging, cumbersome DevOps processes required to organize and securely share research. Through this collaboration Lantern Pharma is expected to benefit from significant efficiencies in development time and cost as well as increased reproducibility from Code Ocean's platform. The Code Ocean platform will offer an easy to use, collaborative research experience with an integrated development environment, secure repository, and portable Compute Capsule technology for guaranteed reproducibility.